Clinical Trial Update: A Clinical Trial to Evaluate the Blood Pressure Control of Telmisartan or Losartan in Essential Hypertensive Patients With Metabolic Syndrome [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating blood pressure control with telmisartan or losartan in patients with essential hypertension and metabolic syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension
• Metabolic Syndrome

Drugs mentioned

• Losartan (losartan)
• Telmisartan (Telmisartan)

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Essential Hypertension, Metabolic Syndrome | Phase 4 | Status: UNKNOWN